Problem with this report is it was based on information or should I say assumptions made prior to SM1 result.
I wonder whether Bell Potter will reassess the theory around rising input costs now that SM1 has reported that A2's input costs have been shown to be declining under their new manufacturing contract.
also with SM1 sticking to production targets it doesn't look like sales growth is falling at all in fact it is accelerating.
- Forums
- ASX - By Stock
- A2M
- Media Updates
Media Updates, page-1525
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.51 |
Change
0.060(1.10%) |
Mkt cap ! $3.808B |
Open | High | Low | Value | Volume |
$5.50 | $5.68 | $5.45 | $20.46M | 3.677M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 45834 | $5.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.53 | 4510 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | 5.630 |
6 | 17273 | 5.610 |
4 | 33072 | 5.600 |
4 | 20359 | 5.590 |
2 | 7656 | 5.580 |
Price($) | Vol. | No. |
---|---|---|
5.650 | 7091 | 2 |
5.670 | 9037 | 3 |
5.680 | 9833 | 4 |
5.690 | 6747 | 2 |
5.700 | 8222 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online